NASDAQ:FACE - Physicians Formula Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $1.16 0.00 (0.00 %) (As of 11/15/2018 07:12 AM ET)Previous Close$1.16Today's Range$1.20 - $1.2052-Week Range$2.76 - $5.14Volume120 shsAverage Volume78,600 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionChartEarningsFinancialsHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Physicians Formula Holdings, Inc. is a United States-based company that manufactures and distributes mass color cosmetics. The Company focuses in color correction and brings department store concepts to the mass market. Its products focus on addressing skin imperfections through a problem-solution approach. Its products address specific, everyday cosmetics needs and include face powders, bronzers, concealers, blushes, foundations, eye shadows, eye liners, brow makeup and mascaras. The Company sells its products in the mass market channel to retailers. Receive FACE News and Ratings via Email Sign-up to receive the latest news and ratings for FACE and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryN/A SectorN/A Current SymbolNASDAQ:FACE Previous Symbol CUSIPN/A Webwww.physiciansformula.com Phone+1-626-3343395 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/A Miscellaneous EmployeesN/A Outstanding SharesN/AMarket Cap$0.00 OptionableNot Optionable Physicians Formula (NASDAQ:FACE) Frequently Asked Questions What is Physicians Formula's stock symbol? Physicians Formula trades on the NASDAQ under the ticker symbol "FACE." Has Physicians Formula been receiving favorable news coverage? News stories about FACE stock have been trending somewhat positive this week, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Physicians Formula earned a coverage optimism score of 1.3 on InfoTrie's scale. They also assigned media headlines about the consumer goods maker a news buzz of 3.0 out of 10, meaning that recent media coverage is unlikely to have an effect on the stock's share price in the near term. How do I buy shares of Physicians Formula? Shares of FACE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Physicians Formula's stock price today? One share of FACE stock can currently be purchased for approximately $1.16. What is Physicians Formula's official website? The official website for Physicians Formula is http://www.physiciansformula.com. How can I contact Physicians Formula? Physicians Formula's mailing address is 1055 W 8th St, AZUSA, CA 91702-2248, United States. The consumer goods maker can be reached via phone at +1-626-3343395. MarketBeat Community Rating for Physicians Formula (NASDAQ FACE)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 58 (Vote Outperform)Underperform Votes: 61 (Vote Underperform)Total Votes: 119MarketBeat's community ratings are surveys of what our community members think about Physicians Formula and other stocks. Vote "Outperform" if you believe FACE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FACE will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 11/15/2018 by MarketBeat.com StaffFeatured Article: What are Institutional Investors?